Status:
RECRUITING
Long-Term Follow-up Study of Early Stage Breast Cancer Patients Included in GEICAM Studies
Lead Sponsor:
Spanish Breast Cancer Research Group
Collaborating Sponsors:
AECC_Asociación Española contra el Cáncer
Conditions:
Invasive Breast Cancer Early Stages
Eligibility:
FEMALE
18+ years
Brief Summary
This is a multicenter, cohorts study to collect information from patients diagnosed with early-stage invasive breast cancer who have been previously included in a neoadjuvant or adjuvant clinical tria...
Detailed Description
One consequence of the improvement in survival rates of certain tumors such as breast cancer is the increase in the number of patients available for long-term follow-up in randomized controlled clinic...
Eligibility Criteria
Inclusion
- Patients included in neoadjuvant and adjuvant clinical trials with GEICAM's participation. If any of these patients had taken part or is participating in another clinical trial, she/he is eligible for this trial and her/his information will also be collected.
- Patients whose death or contact loss has not been previously collected in the databases of the original studies.
Exclusion
- Patient who were not included in the analyses of the original studies due to non-compliance of the eligibility criteria or the original study informed consent withdrawal.
Key Trial Info
Start Date :
January 18 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2048
Estimated Enrollment :
8000 Patients enrolled
Trial Details
Trial ID
NCT03390894
Start Date
January 18 2018
End Date
January 1 2048
Last Update
May 14 2025
Active Locations (73)
Enter a location and click search to find clinical trials sorted by distance.
1
Complejo Hospitalario de Navarra
Pamplona, Navarre, Spain
2
Hospital San Agustín Avilés
Avilés, Principality of Asturias, Spain
3
Hospital Universitario de Canarias
San Cristóbal de La Laguna, Tenerife, Spain
4
Centro Oncológico de Galicia
A Coruña, Spain